SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001045969-02-001585
Filing Date
2002-09-19
Accepted
2002-09-19 13:29:57
Documents
10
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMEND. NO. 1 TO FORM 10-K d10ka.txt 10-K/A 335154
3 LICENSE AGREEMENT WITH SOLVAY PHARMACEUTICALS dex1033.txt EX-10.33 56566
4 LICENSE AGREEMENT WITH BIOSANTE PHARMACEUTICALS dex1034.txt EX-10.34 98592
5 AMEND. NO. 1 TO BIOSANTE LICENSE AGREEMENT dex1035.txt EX-10.35 9939
6 AMEND. NO. 2 TO BIOSANTE LICENSE AGREEMENT dex1036.txt EX-10.36 4559
7 AMEND. NO. 3 TO BIOSANTE LICENSE AGREEMENT dex1037.txt EX-10.37 12185
8 AMEND. NO. 4 TO BIOSANTE LICENSE AGREEMENT dex1038.txt EX-10.38 12885
9 CONSENT OF KPMG LLP dex231.txt EX-23.1 1856
10 CONFIRMING STATEMENT WITH POWER OF ATTORNEY dex241.txt EX-24.1 3830
11 CERTIFICATION FOR SARBANES-OXLEY ACT OF 2002 dex991.txt EX-99.1 1828
  Complete submission text file 0001045969-02-001585.txt   540402
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20945 | Film No.: 02767598
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10